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MethylglyoxalWe introduce the concept of ‘chiral compartmentation’ in metabolism that emerges from the ste-
reo-speciﬁcity of enzymes for their substrate(s). The fully differentiated mammalian erythrocyte
has no sub-cellular organelles and yet it displays compartmentation of lactic acid that is generated
either by glycolysis or the glyoxalase pathway. A form of ‘operational compartmentation’ exists,
based not on the chemistry of the reactive groups in the molecules but their stereoisomerism. This
we call ‘chiral compartmentation’, and the rationale for its ‘natural selection’ in the erythrocyte (and
presumably in the cytoplasm of other cells) is discussed.Increasing awareness of the presence of D-
amino acids in proteins in the otherwise dominant ‘L-chiral biosphere’, and of the preferential use of
one enantiomer of a metabolite versus the other is largely due to recent developments in rapidly-
applicable, analytical–chemical methods. We conﬁrmed that the glyoxalase pathway yields D-lactic
acid by using nuclear magnetic resonance (NMR) spectroscopy of stretched chiral hydrogels. The
activities of the two lactate-producing pathways have been described by numerical integration of
simultaneous non-linear differential equations, based on enzyme models like that introduced by
Michaelis and Menten in 1913.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
1.1. Aims
The 1913 paper by Michaelis and Menten [1] had a remarkable
effect on the development of ideas about factors such as pH, and
reaction products, that affect the rates of enzyme catalyzed reac-
tions in living systems, and the notion of substrate speciﬁcity. In
the spirit of the latter theme we introduce a new ‘categorizing con-
cept’ in metabolism. Hence, we have four speciﬁc objectives: (1) To
reconsider metabolism catalyzed by enzymes as one ‘forum’ in
which evolution of living systems has taken place, and in which
it will continue to do so; (2) describe an example of a ubiquitous
metabolic pathway, the glyoxalase pathway, that exhibits the
phenomenon we call ‘chiral compartmentation’ that relies on thechiral-speciﬁcity of enzymes; (3) present new experimental data
and methodology that conﬁrm the chiral speciﬁcity of this path-
way; and (4) brieﬂy review the use of enzyme kinetics like that
of Michaelis and Menten [1], combined with modern mathematical
methods, to simulate the time dependence of the glyoxalase
pathway.
1.2. Metabolism
Biochemical metabolic charts generally leave the student, who
is new to them, with the impression of overwhelming complexity,
but further study can evoke the realization, in terms of classes of
molecules, that ‘‘so much is achieved with so little’’ e.g.,[2,3]. The
latter comes about because there are, in fact, a very limited, ﬁnite
number of ways of arranging small groups of 3–30 carbon, oxygen,
and hydrogen atoms (along with smaller numbers of nitrogen,
sulfur, phosphorus and other atoms) to make up the ‘toolkit’ of
building blocks that are formed in the network of chemical
inter-conversions in metabolism. During the rearrangements of in-
ter-atomic bonds, various structures are assembled via speciﬁc
Fig. 1. The glyoxalase pathway. In the mammalian RBC methylglyoxal emerges as a
spontaneous side product from phosphorolysis of the reactants (glyceraldehyde 3-
phosphate and dihydroxyacetone phosphate) in the triosephosphate isomerase
catalyzed reaction. Both the ketone and aldehyde groups of methylglyoxal are
spontaneously hydrated, and the free aldehyde reacts spontaneously with free GSH
forming a hemithioacetal; it is the latter which is the substrate for the ﬁrst enzyme
glyoxalase I. Note that the product of this reaction, S-D-lactoyl glutathione, already
has the lactoyl moiety in the D-form. Glyoxalase II catalyzes the hydrolytic cleavage
of its substrate to release GSH and yield D-lactic acid.
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ing system. The set of all possible molecular compounds is dictated
by the valenc(ies) of the constituent atoms (i.e., number of bonds
able to be formed, as categorized by the Periodic Table of Elements
e.g., [4]), the allowed geometry of the structures based on these
atomic valencies, and the relative energies of the formed bonds
that determine their stability. Steric constraints are also imposed
by the volume occupied by substituents bonded to a given atom.
Major geometrical scope and constraints are ‘imposed’ on the
evolution of ‘organic’ metabolic systems by carbon’s valency of
four. Thus one carbon atom can form bonds to four different sub-
stituents with two different possible spatial arrangements that
are mirror images of each other. These, so called, ‘stereoisomers’,
or ‘enantiomers’, that are based around a carbon-atom (referred
to as the ‘chiral centre’) [4] have equal probability of being formed
in a homogeneous chemical and physical environment.
1.3. Chirality and the ‘chiral biosphere’
A consequence of stereoisomerism in organic molecules is that
one enantiomer in solution will rotate the plane of plane-polarized
light in one direction (left or right relative to the incoming beam)
while the other enantiomer will do the opposite. Thus the optical
polarimeter provides an experimental means of distinguishing be-
tween the enantiomers of a given compound. It was observed in
the 19th century, by using this instrument, that the amino acids
that make up proteins are only of the, so called, L-type. Thus Nature
was thought to have selectively ‘chosen’ or ‘committed itself to’
one of the two possible sets of isomers of the amino acids; and
the same conclusion was applied to other chiral molecules because
their inter-conversions are mediated by enzymatic proteins that
are, by their construction from chiral building blocks, intrinsically
chiral. [Ribozymes made of RNA are also constituted from chiral
molecules so the same argument applies to them.] This implied
that only half of the possibilities in the set of all compounds were
‘used’ by Nature. In the case of the amino acids it might have been
concluded that the D-forms were not ‘used’. Actually this is not
correct, and recently modern analytical-chemical methods have re-
vealed the major extent of this ‘violation’ of the dogma [5]; D-ami-
no acids are used in some metabolic contexts, as are other
members of enantiomeric pairs. One notable example of this ‘vio-
lation of the L-only rule’ is the subject of the rest of this paper;
as is a description of a recently described method of distinguishing
members of enantiomeric pairs by using nuclear magnetic reso-
nance (NMR) spectroscopy.
1.4. Glyoxalase pathway
Methylglyoxal is formed in all organisms in several pathways
but most notably, glycolysis [6]. It is a keto-aldehyde and is a side
product of the triosephosphate isomerase (EC 5.3.1.1) reaction aris-
ing from the phosphorolysis of glyceraldehyde 3-phosphate and
dihydroxyacetone phosphate. Since it is cytotoxic (keto-aldehydes
rapidly form Schiff bases and engage in the Maillard reaction with
amines in proteins, denaturing them) [7,8], an efﬁcient pathway
for eliminating it has been ‘naturally selected’: the components
of the pathway are shown in Fig. 1. The enzymes are glyoxalase I
(Zn-containing, lactoylglutathione lyase; EC 4.4.1.5) and II (Zn-con-
taining, hydroxyacylglutathione hydrolase; EC 3.1.2.6) and much is
now known about their mechanisms of action [9–11]. The product
of the pathway has been claimed to be D-lactic acid [12,13], which
leaves the cell and passes via the blood, putatively to the liver
where it enters and is oxidized by peroxisomes [14], and possibly
mitochondria [15], to pyruvate. Glycolysis produces the L-form of
lactate so there is no competition between the glycolytic and the
glyoxalase pathways for reducing equivalents; glycolysis usesNADH and the glyoxalase pathway uses GSH. Also, access to lactate
dehydrogenase (LDH; EC 1.1.1.27) that is speciﬁc for L-lactate is not
available to D-lactate because of the enzyme’s stereo-speciﬁcity.
Thus the cells exploit the phenomenon of ‘redox-selective com-
partmentation’; this is well known to operate between NADH
and NADPH dependent pathways such that isoenzymes of a partic-
ular enzyme in the mitochondria and cytoplasm catalyze the same
chemical reaction but are involved primarily in fuel utilization or
biosynthesis, respectively. Another mechanism of metabolite sepa-
ration we now call ‘chiral compartmentation’: although both path-
ways occupy the same physical space in the cytoplasm of the cell
they are operationally separated by virtue of the speciﬁcity of the
enzymes for their redox co-reactants, and their stereospeciﬁcity.
1.5. Chiral compartmentation
Fig. 2 shows that the three-carbon pyruvic acid (an a-keto car-
boxylic acid) is reduced by its redox co-reactant NADH (and H+) to
yield NAD+ and L-lactic acid (an a-hydroxy carboxylic acid),
whereas the three-carbon a-keto aldehyde, methylglyoxal under-
goes proton relocation in an enolate intermediate [16] with re-
duced glutathione (GSH), followed by hydrolysis of the molecular
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Fig. 2. Chiral compartmentation of L- and D-lactic acid in human red blood cell
metabolism. The schematic diagram shows the 2-keto acid, pyruvic acid that is
achiral, being reduced by the redox co-substrate NADH to L-lactic acid, in a reaction
catalyzed by L-selective lactate dehydrogenase. On the other hand, methylglyoxal is
hydrated via two enzyme-catalyzed reactions to yield D-lactic acid. The ﬁrst
reaction involves the simultaneous reduction of the keto-aldehyde and formation of
a thioester, with redox co-substrate GSH. The second reaction recycles the GSH and
releases the product. Because highly abundant water is the co-substrate in the
second reaction ‘mass-action’ ensures that the process is unidirectional. Because
the product is the D-stereoisomer of lactic acid it does not drive the adjacent L-
lactate dehydrogenase reaction in the reverse direction, as represented by the red
cross on the dotted arrow.
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same chemical compound (lactic acid) but with opposite stereo-
isomerism. While the glyoxalase pathway occurs in virtually all
of Biology, it is useful to consider the special case of the human
erythrocyte (red blood cell; RBC) in which it has been kinetically
(in the Michaelis–Menten sense) well characterized [17]: the RBC
is dependent on a constant supply of ATP to maintain its transmen-
brane cationic disequilibrium, synthesize GSH, and phosphorylate
proteins in the cytoskeleton e.g., [18]. This ATP generation occurs
via substrate-level phosphorylation in glycolysis. RBCs have no
mitochondria so the NAD+ involved at the glyceraldehyde-3-phos-
phate dehydrogenase (EC 1.2.1.12; GAPDH) reaction generates
NADH that is recycled to NAD+ at the end of glycolysis via LDH that
catalyzes the conversion of pyruvate to lactate e.g., [19–22]. If
extraneous L-lactate were to enter the reaction mixture (cyto-
plasm) then by virtue of ‘mass action’ it would bias the LDH reac-
tion in the reverse direction. Thus the GAPDH reaction, and hence
overall glycolytic ﬂux, would be reduced. However, the cell has a
very speciﬁc demand for a continuous supply of ATP so perturba-
tion of this supply needs to be ‘‘guarded against’’; therefore if the
extraneous lactate were produced incessantly in the same com-
partment (e.g., via triosephoshate isomerase) and also entered
from outside the cell, a ‘‘work-around’’ would provide a selective
advantage to the whole organism in terms of better control of
ATP supply in the RBC. In the case of the glyoxalase pathway, obvi-
ously in principle the two enzymes could have been L-enantiomer
speciﬁc and used NADH as the co-reactant, but they have been nat-
urally selected, ensuring that the critical moiety-conservation cy-
cle of NAD+–NADH, with its very limited pool-size of 0.1 mM, is
not interfered with. This has been achieved by using the much
more abundant GSH as the co-reactant (thus making it able to rap-
idly react to a large inﬂux of methylglyoxal), which has a similar
standard redox potential (0.23 V versus 0.32 V [3]) to NAD+/
NADH + H+, and generate D-lactate that does not bind (with the
high afﬁnity of L-lactate) to L-lactate dehydrogenase.
L-Lactate leaves the RBC via a monocarboxylate transporter
[23], and is further oxidized to CO2 in other tissues, such as the
heart and liver. The fate of the D-lactate is not as well understood,
but it is known that the RBC membrane is rapidly permeated onthe 1-min timescale [Naumann and Kuchel unpublished results];
and peroxisomes in hepatocytes are the site of D-lactate oxidase
[14], while mitochondria possess D-lactate dehydrogenase (EC
1.1.1.28) activity [15], both of which generate pyruvate that can
be oxidized to CO2 via the Krebs cycle.
In conclusion, chiral compartmentation ensures that glycolytic
ﬂux and hence ATP production remains very uniform even if meth-
ylglyoxal concentration in an RBC ﬂuctuates. Blood cells ‘‘visit’’ all
tissues of the body, some of which potentially export methylgly-
oxal at various rates so the concentration in the RBC will vary on
the time scale of the circulation viz., 1 min.
1.6. Numerical simulation of the glyoxalase pathway
A striking feature of the glyoxalase pathway is the rapidity of
its ﬂux. This was implied in the earlier literature but it was starkly
evident when the glyoxalase pathway was ﬁrst studied by using
1H NMR spectroscopy in human RBCs [17]. While the original
aim of that work was to characterize the kinetics of the enzymes
in the intact cells, the reactions were too fast to ‘‘catch’’ with
sequential 1H NMR spectra. Haemolysates that corresponded to
a haematocrit (Ht) of 5% had to be used. However, what was
sought was a means of predicting the metabolite ﬂux in vivo. To
achieve this a mathematical model was constructed and run using
the computational methods used for simulating time courses of
other metabolic pathways. An important aspect of this modelling
was the derivation of steady-state rate equations for each of the
enzymes. To achieve this we used the method of King and Altman
[24], but in a modern reincarnation of this graphical method that
is presented in Appendix I of [19]. In this Mathematica [25]
program we use the insightful, compact procedure presented ﬁrst
in [26]. The input to this program is a table that describes the
unidirectional, unitary reactions, ‘to’ and ‘from’, each enzyme
complex in the speciﬁed reaction mechanism; and the program
uses symbolic computation to automatically generate a steady-
state rate expression.
The non-linear differential equations that describe the reaction
scheme (metabolic pathway) are rapidly solved in Mathematica
[25] and similar programs. The model of the glyoxalase pathway
in human RBCs by Rae et al. [17] used steady-state equations of
the Michaelis–Menten type and more recently the metabolism of
methylglyoxal and the kinetics of its modiﬁcation of proteins in
Chinese hamster ovary cells has been modeled using mostly phe-
nomenological ﬁrst and second-order reactions [27].
Overall, there is a strikingly greater rate of methylglyoxal dis-
posal relative to the generation of L-lactate in glycolysis; but quan-
titative comparisons of the ﬂuxes in the two pathways under
various experimental conditions can now be made by using the
computer models of both pathways [17,19–22].
1.7. Experimental observation of chiral speciﬁcity
In exploring the possible generality of the phenomenon of chiral
compartmentation it is essential to have various means of identify-
ing one enantiomer of the molecule of interest from the other. As
noted above, this characterization was ﬁrst achieved by using the
‘optical activity’ of chiral compounds. More recently the parti-
tion-coefﬁcient of chiral molecules in a chiral chromatographic
medium have been shown to differ; this can be exploited in the
identiﬁcation of enantiomers because of the different elution times
from a chromatography column packed with the medium [28,29].
A much less invasive approach, requiring less arduous extraction
procedures and sample ﬁltration involves NMR spectroscopy. This
has only recently been developed using chiral hydrogels containing
guest molecules of interest and the gels are held stretched while
the spectra are recorded [30–36].
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lar type of guest molecule (including mixtures of them) interact
with the medium in several ways: electrostatically (ionic), by
hydrogen bonding, via the hydrophobic effect, and van der Waals
forces; but importantly, the contribution of each to the net binding
interaction depends on the geometry of both binding partners.
Therefore, with a matrix such as gelatin, which is composed of pro-
tein consisting of L-amino acids (especially proline, hydroxyproline
and alanine) and achiral glycine, a free L-amino acid or L-lactate
will bind differently from their corresponding D-stereoisomer.
The same applies for chiral-carbohydate gels such as the carrag-
eenans [30–37]. In an NMR experiment this means that the shield-
ing of the external magnetic ﬁeld by the electron ‘clouds’ around
the resonant nucleus will differ for each type of enantiomer; in
addition, the extent to which the magnetic dipoles of the nuclei
in adjacent atoms on the molecule, inﬂuence the local magnetic
ﬁeld of the nucleus of interest, varies with the binding state of
the whole molecule. In free solution the effect of this dipole–dipole
interaction is averaged by molecular tumbling that occurs on a
timescale much faster than the nuclear magnetic relaxation time,
in the NMR experiment [38]. However, if the molecules of the ma-
trix, with their chiral binding sites, are aligned relative to the mag-
netic ﬁeld of the NMR spectrometer, then the spectral resonances
(peaks) are split into components that may be separated by large
frequency differences. Partial alignment of the matrix polymers
with the main magnetic ﬁeld of the NMR spectrometer is achieved
by holding the gel in a stretched state. The magnitude of the peak
splitting is a function of the extent of stretching, and at the molec-
ular level it also depends on the mean residence time of the solute
in its bound state, and the chemical nature of the binding. Further-
more, in a mixture of stereoisomers, such as lactic acid, the extent
of dipolar splitting will differ for the L- and D-forms. (Strictly speak-
ing, the splitting is referred to as ‘residual dipolar splitting’ because
in solution, even in a gel, the extent of splitting is much less than
that which would occur in the solid state.)
We now consider the experimental veriﬁcation of the product
of the glyoxalase pathway as D-lactic acid with this new NMR
method. It was ﬁrst claimed by Racker in 1953 that the two glyox-
alases acting in concert generated D-lactic acid [12] from methyl-
glyoxal. This conclusion was based on the non-oxidation of the
product by muscle L-lactate dehydrogenase. However Racker
claimed that S-L,D-lactoylglutathione that was hydrolyzed by puri-
ﬁed glyoxalase II generated the corresponding lactic acid enantio-
mer, thus implying that the chiral speciﬁcity of the glyoxalase
pathway resides in glyoxalase I [39].
More deﬁnitive evidence of the product being D-lactate was pre-
sented by Ekwall and Mannervik [13]. Glyoxalase I puriﬁed from
porcine RBCs was incubated with GSH and methylglyoxal and the
chiral-speciﬁcity of D-lactate dehydrogenase from Lactobacillus
leichmanii was used to conﬁrm Racker’s claim. Notwithstanding
these compelling conclusions we sought to verify this ﬁnding by
a more direct and visual method (spectroscopy), and concomi-
tantly develop methodology that does not require a chiral-speciﬁc
enzyme for each metabolite whose enantiomeric form is to be
determined. This is described next in what is the main experimen-
tal part of the paper.
2. Materials and methods
2.1. RBCs
Fresh RBCs were obtained from healthy donors by venipuncture
and washed in isotonic saline (154 mM NaCl; osmolality measured
to be 290 mOsmol kg1) with 10 mM glucose. The cells were cen-
trifuged (10 min, 4 C, 3000g) and the supernatant and ‘buffy
coat’ were aspirated. This procedure was repeated twice, followedby bubbling with CO for 10 min (to render the haemoglobin into a
stable diamagnetic state thus improving the signal-to-noise of the
subsequent NMR spectra). After the ﬁnal wash the haematocrit
was 85%, and this sample was diluted to a ﬁnal value of 40%
in incubations with methylglyoxal, from which lactic acid was
extracted.
2.2. NMR
1H NMR spectra were recorded at 400.13 MHz, and 2H NMR
spectra were recorded at 61.422 MHz, on a Bruker (Karlsruhe, Ger-
many) Avance III spectrometer, with a 9.4 T Oxford Instruments
(Oxford, UK) vertical wide-bore magnet. The spectrometer was
equipped with a 5-mm transmit X-nucleus coil inside (TXI), or a
10-mm broadband observe (BBO) probe. The temperature was cal-
ibrated using methanol and set to 288 K (15 C) for the gel samples.
NMR data were processed using TopSpin 3.0 (Bruker), and the
spectra were extracted as a text ﬁle that was read in Mathematica
[25]. All spectra were phased and baseline corrected prior to anal-
ysis; line broadening factors of 0.3 Hz, and 1.0 Hz were used for 1H
and 2H spectra, respectively; the 1H2O resonance (peak) in 1H spec-
tra and the HOD peak in 2H spectra were set to a chemical shift of
4.79 ppm.
2.3. Chemicals
Isotopically labeled and other chemicals were obtained from
the following suppliers: pyruvaldehyde dimethyl acetal, Aldrich,
Milwaukee, WI, USA; sodium [3,3,3-2H] D,L-lactate (d3-lactate); so-
dium [2,3,3,3-2H] D,L-lactate (d4-lactate), and the individual isotop-
omers, Merck, Montreal, Canada; sulfuric acid-d2, Merck, Montreal,
Canada; sodium D()-lactate, Boehringer Mannheim, Germany;
lithium L-lactate, Calbiochem, San Diego, CA, USA. Gelatin was from
bovine skin and supplied by Gelita, Qld, Australia.
2.4. Methylglyoxal preparation
The method of preparation was essentially that of Kellum et al.
[40]: Pyruvaldehyde dimethyl acetal (1 ml) was mixed with con-
centrated H2SO4 (200 ll) and H2O (9 ml) in a volumetric ﬂask that
was loosely sealed, and heated at 60 C in a water bath for 4 h.
The ﬂask and contents were then cooled to room temperature over
30 min before being heated to 100 C for 30 min. After allowing
the solution to cool, the pH was adjusted to 7.4 with 1 M NaOH
and transferred to a 50 ml sample tube and snap frozen in liquid
nitrogen; this was then lyophilized over 24 h. The product was
a sticky pale yellow powder and it was seen by 1H NMR spectra
to be protonated methylglyoxal but also including the hydrated
forms [17].
Deuterated methylglyoxal was made by the same method as
above but with H2SO4 and H2O replaced by D2SO4 and D2O,
respectively.
2.5. Glyoxalase pathway product
RBCs (haematocrit 40%) were suspended in phosphate buf-
fered saline (PBS; 140 mM NaCL, 20 mM glucose; and 20 mM
NaH2PO4). A known concentration of either protonated or deuter-
ated methylglyoxal was dissolved in PBS prior to addition to a sus-
pension of RBCs, at 37 C. Penicillin G and streptomycin (75 lM)
were included to prevent bacterial contamination. Samples of
1.5 ml of the RBC suspension were removed at speciﬁed times dur-
ing the incubations, and placed in an Eppendorf centrifuge (Model
5415D, Hamburg, Germany; 30 s 13000g) to yield a supernatant
that was snap-frozen in liquid nitrogen and then lyophilized. Alter-
natively, samples (haematocrit 40%) were treated with an equal
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The supernatant was neutralized with 3 M K2CO3 and the superna-
tant, obtained after re-centrifugation, was lyophilized. The result-
ing powder was dissolved in methanol leaving behind the KClO4.
The decanted methanol contained the lactic acid that was recov-
ered as a dry powder after evaporating the methanol under a
vacuum.
2.6. Stretched gelatin gels
These were prepared as described previously [30,31,36]: brieﬂy,
the liquid gelatin solutions containing the supernatant-extracts
from RBCs that had been incubated with methylglyoxal were
drawn into silicone rubber tubes (Silastic laboratory tubing, Dow
Corning Corp., Cat. No. 508-009, 1.98-mm inner diameter,
3.18 mm outer diameter). Then a Delrin plug was inserted in one
end leaving no air-gap between it and the liquid gelatin. The sam-
ple was cooled to 4 C to cause gelation (this is mediated by hydro-
gen bonding that is enhanced at lower temperatures) and the tube
was then inserted into a close-ﬁtting 5-mm open-bottom glass
tube, ready for NMR analysis. The silicone tube and its contents
were stretched by a factor up to twice the original length and then
held in this state with a Delrin thumb-screw that rested on the
upper shoulder of the glass tube [30,31,36].
3. Results
3.1. 1H NMR of D- and L-lactic acid
Fig. 3 is a schematic representation of the scalar and dipolar
interactions between the 1H-atoms on the methyl and methine
groups of lactic acid. In an aligned gel, these interactions cause
splitting of the –C1H3 resonance in the 1H NMR spectrum, in the
manner shown on the left of the diagram. Speciﬁcally, there is
through-bond, scalar coupling between the methyl and methine
protons that generates a doublet (that is expressed independently
of whether there is molecular alignment); and there are also dipo-
lar, through-space interactions between the three 1H-atoms of the
methyl group generating a triplet, and also with the 1H-atom of the
methine generating a doublet. With these three simultaneousFig. 3. Schematic representation on the left of the resonance splitting that occurs in
the 1H NMR spectra of the methyl group of lactic acid. On the right is the chemical
formula of lactic acid: the arrows indicate the intra-methyl (brown) and methyl-
methine (magenta) dipolar interactions whose magnitudes are D (Hz), while the
mutual scalar couplings between the three H atoms has magnitude J (Hz). The green
sections of the molecule do not affect the spectral features of the methyl resonance
in the present context.interactions the methyl resonance is split into six components, a
so-called ‘doublet of doublet of triplets’.
The splitting was made evident in lactate in stretched gelatin
gels, as seen in Fig. 4B, which was obtained from a 1:1 mixture
of L- and D-lactate. The stretching aligns the molecules of dena-
tured collagen in gelatin, and the lactate binds to the side chains
in a stereo-speciﬁc way. Thus the splitting patterns of the spectra
of the L- and D-forms have the same number of components (six)
but the separation (in Hz) between them differ, so the combined
spectrum has 10 (in some cases only partially resolved) compo-
nents implying the obscuring of two of the components.
However, by using spectral deconvolution (Fig. 4A) it was
possible to obtain an estimate of the relative proportions of L-
and D-lactate in a mixture; in this case it was 1:1, within experi-
mental error.
By using this approach it was shown that the lactic acid ex-
tracted from the incubation mixture of fresh human RBCs and
methylglyoxal had a splitting pattern indicative of D-lactic acid.
This was done by adding the extract to a racemic mixture of lactate
to obtain an underlying internal reference spectrum (Fig. 4B). On
the other hand an extracted supernatant from RBCs incubated with
glucose alone gave a splitting pattern indicative of L-lactic acid
(data not shown).Fig. 4. 1H NMR (400.13 MHz) spectra of the methyl region of D- and L-lactate in
stretched gelatin (63% w/w) gel, at 15 C. (A) deconvolution of the real spectrum;
the L and D labels refer to the respective stereoisomer. (B) spectrum from racemic
(1:1) mixture of D- and L-lactate; the assignments were based on similar
experiments performed with commercially supplied pure L- and pure D-lactate.
(C) spectrum of the supernatant extract obtained from incubating RBCs with
methylglyoxal added to a racemic mixture (1:1) of D,L-lactate; note the enhance-
ment of the ‘‘D’’ peaks only, especially those centered at ±30 Hz indicating that the
extract contained only D-lactate. The coloured segments in the spectrum were used
to highlight the peaks that are uniquely assignable to L- (blue) and D- (green)
lactate. The offset frequency was set to 0.000 Hz at the centre of the methyl
complex, and the chemical shift scale is given in Hz for ease of comparison of
splitting patterns (that vary sensitively with the extent of gel stretching and
composition) between spectra shown in the other ﬁgures.
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The 1H NMR spectral multiplets in Fig. 4 are not fully resolved,
and while the method is deﬁnitive for many enantomeric mixtures
of small molecules, there is another form of splitting that can be
elicited in stretched gels that is much larger e.g., [31,37]. Deute-
rium is a quadrupolar nucleus (spin = 1) and when it is present
in a ‘labelled’ molecule in an aligned medium, its electric quadru-
pole moment interacts with the non-degenerate electric-ﬁeld gra-
dients (described as a tensor) around the aligned polymers. Thus
its NMR resonance is split into a doublet. The extent of splitting
is often an order of magnitude greater than the dipolar splitting
evident in Fig. 4; furthermore the magnetogyric ratio (that charac-
terizes the magnitude of its magnetic dipole), c, of 2H is 1/6th that
of 1H, the values of the scalar coupling constant, J, and the residual
dipolar coupling constants, D, are correspondingly much smaller.
Therefore the 2H NMR spectrum of aligned 2H-labelled lactate
shows only the quadrupolar-split doublet while the effects of the
other interactions are not resolved.
Commercially obtained deuterium-labelled L- and D-lactate, and
the lactate extracted from RBCs incubated with deuterated methyl-
glyoxal, incorporated into gelatin gels that were stretched, gave the
spectra shown in Fig. 5. Fig. 5A was obtained from the racemic
mixture. There were eight peaks and the doublet assigned to theFig. 5. 2H NMR (61.422 MHz) spectra of a deuterated lactate in stretched gelatin gel
at 15 C, using an extension factor of 1.0. (A) Li D,L-lactate-d4 in 50% gelatin (w/v),
17.5 cm tube stretched 20 cm (extension factor 1.14), giving quadrupolar splittings
(Hz): HDO, 592; L-lactate methyl 99.8; and D-lactate methyl 56.5. (B) Supernatant
extract from RBCs incubated with methylglyoxal plus sodium D,L-lactate-d4, 15.2 cm
tube stretched 16 cm (extension factor 1.05), giving the quadrupolar splittings (Hz):
HDO, 588; L-lactate methyl 104; and D-lactate methyl 61. (C) Li D,L-lactate-d4 in 50%
gelatin (w/v) in a 16.2 cm tube, stretched 24 cm (extension factor 1.48), giving the
quadrupolar splittings (Hz): HDO, 668; L-lactate methyl 113.5; and D-lactate methyl
65.1. (D) Supernatant extract from RBCs incubated with methylglyoxal, in 30% (w/
w) gelatin gel in a 15.2 cm tube stretched 20 cm (extension factor 1.32), giving the
quadrupolar splittings (Hz): HDO, 662; and D-lactate methyl 70. Asterisks indicate
peaks from the methines of D- and L-lactate, respectively, while the other
component of each doublet is hidden under the methyl-peak complex. (B and D)
had no added D2O so the (small) HDO resonance arose from dissociation of
deuterated solutes in the extracts.deuterium in the D2O used in composing the sample had a residual
quadrupolar coupling constant of600 Hz,10 the splitting seen
in the 1H spectra in Fig. 4. This splitting is very sensitive to, and di-
rectly proportional to the extent of stretching of the gel [34,36].
The two peaks at 220 Hz and 100 Hz were assigned to the
methine 2H-atoms; they were assigned by analogy with very sim-
ilar spectra obtained from D,L-alanine-d4 [31]. Likewise the four
peaks at 220 Hz were assigned to the 2H-atoms in the methyl
group. It was clear that the doublet from the D-isomer was substan-
tially less separated than for the L-isomer; this bode well for the
deﬁnitive identiﬁcation of the chiral form of lactate generated by
RBCs from methyl glyoxal. Therefore, since it is a simple matter
to label methylglyoxal with deuterium we used this isotopomer
in RBC incubation experiments.
Fig. 5B was obtained from an extract of RBCs incubated with
methylglyoxal that was added to a racemic (1:1) mixture of D,L-lac-
tate as internal reference. It is clear that the central two peaks were
substantially enhanced relative to the racemic mixture alone
(Fig. 5A); this implied that the extract contained deuterium-la-
belled D-lactate. Fig. 5C was obtained from a sample similar to that
for Fig. 5A and because the gel was stretched more the low-fre-
quency HDO peak was resolved away from that of L-lactate. In
addition, the separation between the D- and L-methyl resonances
was increased by this greater extent of stretching. Finally, Fig. 5D
is a spectrum obtained from an extract of RBCs incubated with
methylglyoxal with a similar gel composition and extent of
stretching as for Fig. 5A, and it shows two peaks at the same chem-
ical shifts as for the D-lactate therein. This conﬁrmed the lactate as
the D-form.
While the previous spectra had conﬁrmed D-lactate as the prod-
uct of the glyoxalase pathway, it was useful to determine the rela-
tive values of the quadrupolar splitting of the two 2H-labelled
enantiomers. This analysis is required when designing an experi-
ment to resolve any enantiomers, to ensure that for a given con-
centration of gelatin and extent of stretching the relevant peaks
are resolved. For the lactate the quadrupolar splitting of the methyl
resonance, relative to that of water (which has the largest splitting)
was 0.100 ± 0.004 for the D-form, and 0.195 ± 0.007 for the L-form.
The peaks were well resolved under the experimental conditions
used for Fig. 5, viz., 63% (w/w) gelatin with stretching to twice
the original length of the gel in the silicone rubber tube.
4. Discussion
4.1. D-Lactate assignment
Figs. 4–6 contain the 1H and 2H NMR spectral information that
convincingly showed that the product of methylglyoxal metabo-
lism by human RBCs is the D-enantiomer of lactic acid, thus con-
ﬁrming the earlier claims and report based on separately
established LDH and lactate oxidase stereo speciﬁcity [12,13,39].
The stretched chiral-hydrogel methodology coupled with NMR
spectroscopy is applicable to resolution of similar issues for other
metabolites [31–36]. It has advantages over previousmethods since
it does not require enzymes of known stereo speciﬁcity, and sample
preparation is simple. In addition spectral output provides visually
convincing interpretations of the underlying molecules; and even if
spectra are not fully resolved numerical deconvolution enables
quantiﬁcation of peak areas, and hence estimates of relative quan-
tities of particular molecular species in a sample.
4.2. Another example of chiral compartmentation
There are numerous examples of chiral compartmentation,
especially in bacteria, and yet a recent instance in mammals has
emerged: the male Australian platypus produces a venom that
Fig. 6. Residual quadruploar couplings in 2H NMR (400.13 MHz) spectra of L- and D-
lactate in D2O/H2O (20% v/v) solvent in stretched gelatin (63% w/w) gel, at 15 C.
Key: Black squares, L-lactate in D,L-lactate-d4 (2.2 M) racemic mixture; red discs, D-
lactate in D,L-lactate-d4 (2.2 M) racemic mixture; blue inverted triangles, L-lactate in
D,L-lactate (2.5 M) racemic mixture added to methylglyoxal-reaction mixture from
RBCs; pale blue diamonds, L-lactate-d3 (50 mM) alone; and green triangles, D-lactate
in D,L-lactate (2.5 M) racemic mixture added to methylglyoxal-reaction mixture
from RBCs. The solid lines were regressed onto the data and had slopes of
0.100 ± 0.004 Hz/Hz, and 0.195 ± 0.007 Hz/Hz, for the splitting of D- and L-lactate,
respectively.
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position from the N-terminus [41–44]. The alternative enantiomer
is formed by a speciﬁc L/D-peptide isomerase with a characteristic
speciﬁcity for a particular N-terminal tripeptide sequence [45–47].
Chiral compartmentation applies after envenomation: the D-con-
taining peptide is resistant to aminopeptidase which is L-speciﬁc.
Hence the venom component will reside in the tissue of the victim
for longer that would otherwise have been the case because the
D-amino-acid-residue-containing peptide is ‘operationally com-
partmentalized’ from L-speciﬁc aminopeptidase(s). Thus we specu-
late that a selective advantage exists for the platypus to have
venom components that persist for longer in the envenomated
victim.
There are likely to be other selective advantages in other species
for possessing the newly described peptide isomerase. Platypus-
type peptide isomerase activity has been discovered in plants
and higher mammals [48,49] and in these instances the modiﬁed
peptide will be resistant to the usual L-speciﬁc aminopeptidases.
No matter what its role the modiﬁed peptide/protein will persist
longer than its all-L-counterpart unless there is a D-speciﬁc removal
system (yet to be discovered) that is faster. This speculation awaits
investigation and will be enhanced by a genome wide analysis of
the distribution of the peptide isomerases within a species
between tissues and subcellular compartments and between
species.
4.3. ‘‘Cross-talk’’ between chiral compartments
This phenomenon could be based on effector-site speciﬁcity for
D- and L-forms of effectors. It has a counterpart in the more familiar
physical compartmentation for which there may be selectivity via
stereo-speciﬁc transport proteins that mediate the inter-compart-
mental exchange. Again, this aspect of chiral biochemistry is
largely unexplored [5].
4.4. Evolution of metabolic complexity
Having identiﬁed the phenomenon of chiral compartmentation
we can question how it might have evolved since the origin of life
on Earth. This is not a mere classiﬁcation of biochemical pathways
but is subjectable to experimental enquiry via genome sequences
that will be able to identify when D-speciﬁcity of glyoxalase I arose.We suggest one sequence of events is: D,L-primaeval ‘soup’? ‘ﬂuc-
tuation’ in relative population sizes of enantiomers? bias towards
and then ampliﬁcation of selection of L-amino acids? L-dominant
biosphere? formation of membranes and physical sub-compart-
ments? chemical ‘cross talk’ between physical compart-
ments? exhaustion of possibilities for small molecules (the key
driver for chiral compartmentation)? ﬂuctuation of enzyme
stereo-speciﬁcity to give D-alternative enzymes (same ‘chemis-
try’)? cross talk between chirally-speciﬁc effector-controlled
enzymes.
So, what was the sequence of evolutionary events leading to the
glyoxalase pathway generating D-lactic acid rather than L-lactic
acid? We speculate that since glycolysis is found in the most an-
cient of organisms the deleterious effects of methylglyoxal (gener-
ated as a side product of the triosephosphate isomerase reaction)
were next selected against by the evolution of at least a system
of conjugation (with GSH or similar) and conversion to lactic acid.
We postulate that chiral compartmentation evolved after a dis-
posal pathway (the two glyoxalases) for methylglyoxal had arisen
and that the D-selective pathway was a later trait. Therefore we
predict the existence of some organisms (primitive) that lack the
glyoxalase pathway, and also later developments in those with a
pathway that yields L-lactic acid. Such enzymes may have evolved
to display promiscuity towards the two stereoisomers (such as the
‘‘back door access’’ demonstrated in a ribozyme [50]) and later nat-
ural selection favoured the organisms with glyoxalase I, at least,
that possess D-speciﬁcity.
5. Conclusions
Overall, we describe the operational separation of the reactions
of the glycolytic and glyoxalase pathways in the homogeneous
cytoplasm of the RBC, and how these can be studied by NMR spec-
troscopy. The stretched-gel method is readily applied to other sys-
tems and will be useful in the search for different enantiomeric
selections in metabolism.
NMR spectroscopy is used to monitor biochemical reactions in
intact cells; thus large data sets of times courses of the operation
of the glyoxalase pathway have been recorded. From a knowledge
of the kinetics of the enzymes in the pathway studied in isolation,
times courses of its operation can be simulated for in vivo situa-
tions. We already have a contemporary means of doing this
e.g.,[19].
The glyoxalase pathway has very high ﬂux capacity which af-
fords a ‘‘knee-jerk’’ reaction by the cell to the presence of methyl-
glyoxal, but the fate of the emergent D-lactate is not fully
understood and awaits future investigation.
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